|
Welcome to datamethods
|
|
1
|
11514
|
July 24, 2018
|
|
RMS Discussions
|
|
332
|
70943
|
April 26, 2024
|
|
Using splines with time series data
|
|
5
|
82
|
April 26, 2024
|
|
Biomarker selection
|
|
4
|
89
|
April 26, 2024
|
|
Data reduction strategy in Cox PH model and validate() interpretation
|
|
13
|
362
|
April 22, 2024
|
|
Can we think of competing-event as another form of non-event in terms of utility?
|
|
0
|
94
|
April 21, 2024
|
|
RMS General Regression
|
|
112
|
29468
|
April 19, 2024
|
|
Resources for Learning Likelihood and Bayesian Methods
|
|
3
|
2174
|
April 19, 2024
|
|
Biomarker evaluation - c-statistic (AUC) and alternatives
|
|
24
|
1798
|
April 18, 2024
|
|
Optimal timing for rescue strategy after repeated failed treatment attempts
|
|
3
|
124
|
April 18, 2024
|
|
Penalized Likelihood vs. Variance Decomposition Approaches
|
|
2
|
1911
|
April 17, 2024
|
|
How should an early warning system be validated?
|
|
13
|
304
|
April 17, 2024
|
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
98
|
April 17, 2024
|
|
RMS Missing Data
|
|
31
|
24672
|
April 17, 2024
|
|
Choosing the best functional form for variable in Cox model: an added layer of complexity
|
|
1
|
210
|
April 16, 2024
|
|
How do I analyse the functional form of the relationship between a covariate to the hazard ratio in a Cox proportional hazard model?
|
|
8
|
1761
|
April 12, 2024
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
5
|
6531
|
April 11, 2024
|
|
Case-Cohort Design - longitudinal ordinal outcome with interval-censoring
|
|
2
|
120
|
April 11, 2024
|
|
Counterfactual Prediction + Longtitudinal Ordinal Models + Decision Making
|
|
7
|
930
|
April 11, 2024
|
|
Overlap weights for small sample RCTs
|
|
18
|
435
|
April 11, 2024
|
|
ML Approaches with censored data
|
|
3
|
131
|
April 11, 2024
|
|
RMS Ordinal Regression for Continuous Y
|
|
70
|
23981
|
April 10, 2024
|
|
Double Counting in Meta-Analysis
|
|
3
|
159
|
April 10, 2024
|
|
Hybrid AI & Delphi Based Derivation of RCT and Bedside Measurements
|
|
10
|
490
|
April 10, 2024
|
|
Basic general doubt about Mendelian randomization
|
|
5
|
310
|
April 9, 2024
|
|
Sample size calculation for metabolomic profiles in a nested case-control study
|
|
0
|
136
|
April 8, 2024
|
|
Use of percentage change in clinical trials
|
|
16
|
627
|
April 8, 2024
|
|
When is it clinically reasonable to assume transportability of RCT effects?
|
|
7
|
239
|
April 7, 2024
|
|
Immortal-time-bias vs. selection bias
|
|
2
|
188
|
April 7, 2024
|
|
RMS Describing, Resampling, Validating, and Simplifying the Model
|
|
158
|
39630
|
April 4, 2024
|